Annual Total Liabilities
$153.19 M
+$24.89 M+19.41%
31 December 2023
Summary:
Verve Therapeutics annual total liabilities is currently $153.19 million, with the most recent change of +$24.89 million (+19.41%) on 31 December 2023. During the last 3 years, it has risen by +$10.86 million (+7.63%). VERV annual total liabilities is now at all-time high.VERV Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$155.35 M
+$539.00 K+0.35%
30 September 2024
Summary:
Verve Therapeutics quarterly total liabilities is currently $155.35 million, with the most recent change of +$539.00 thousand (+0.35%) on 30 September 2024. Over the past year, it has increased by +$3.32 million (+2.18%). VERV quarterly total liabilities is now -33.78% below its all-time high of $234.60 million, reached on 31 March 2021.VERV Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.4% | +2.2% |
| 3 y3 years | +7.6% | +498.9% |
| 5 y5 years | - | - |
VERV Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +472.2% | at high | +770.3% |
| 5 y | 5 years | at high | +472.2% | -33.8% | +770.3% |
| alltime | all time | at high | +472.2% | -33.8% | +770.3% |
Verve Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $155.35 M(+0.3%) |
| June 2024 | - | $154.82 M(+3.7%) |
| Mar 2024 | - | $149.29 M(-2.5%) |
| Dec 2023 | $153.19 M(+19.4%) | $153.19 M(+0.8%) |
| Sept 2023 | - | $152.04 M(+22.7%) |
| June 2023 | - | $123.91 M(-0.8%) |
| Mar 2023 | - | $124.90 M(-2.6%) |
| Dec 2022 | $128.29 M | $128.29 M(+2.3%) |
| Sept 2022 | - | $125.41 M(+349.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $27.93 M(+56.5%) |
| Mar 2022 | - | $17.85 M(-33.3%) |
| Dec 2021 | $26.77 M(-81.2%) | $26.77 M(+3.2%) |
| Sept 2021 | - | $25.94 M(+22.8%) |
| June 2021 | - | $21.12 M(-91.0%) |
| Mar 2021 | - | $234.60 M(+64.8%) |
| Dec 2020 | $142.32 M(+245.4%) | - |
| Dec 2020 | - | $142.32 M |
| Dec 2019 | $41.20 M | - |
FAQ
- What is Verve Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Verve Therapeutics?
- What is Verve Therapeutics annual total liabilities year-on-year change?
- What is Verve Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Verve Therapeutics?
- What is Verve Therapeutics quarterly total liabilities year-on-year change?
What is Verve Therapeutics annual total liabilities?
The current annual total liabilities of VERV is $153.19 M
What is the all time high annual total liabilities for Verve Therapeutics?
Verve Therapeutics all-time high annual total liabilities is $153.19 M
What is Verve Therapeutics annual total liabilities year-on-year change?
Over the past year, VERV annual total liabilities has changed by +$24.89 M (+19.41%)
What is Verve Therapeutics quarterly total liabilities?
The current quarterly total liabilities of VERV is $155.35 M
What is the all time high quarterly total liabilities for Verve Therapeutics?
Verve Therapeutics all-time high quarterly total liabilities is $234.60 M
What is Verve Therapeutics quarterly total liabilities year-on-year change?
Over the past year, VERV quarterly total liabilities has changed by +$3.32 M (+2.18%)